美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant

0.1000

0.0000

成交量：- -

成交額：68.36

市值：41.04萬

市盈率：- -

高：0.1000

開：0.1000

低：0.1000

收：0.1000

52周最高：0.1560

52周最低：0.0200

股本：410.45萬

流通股本：410.45萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：-127.46%

總資產收益率：-71.91%

市淨率：-0.12

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

60 Degrees Pharmaceuticals攜手Runway Health為國際旅行者提供瘧疾預防藥物Arakoda®直供服務

60度製藥公司讚助研究顯示：北卡羅來納州立大學同行評審發現24%慢性疲勞患者存在巴貝西蟲感染

60 Degrees Pharmaceuticals 宣佈 B-Free 慢性巴貝斯病研究的臨床試驗中心已開放病人入組，地點位於西奈山伊坎醫學院

60 Degrees Pharmaceuticals宣佈在複發性巴貝斯蟲病研究中，首位患者接受塔非喹治療後未發現巴貝斯蟲感染

60 Degrees Pharmaceuticals公布慢性巴貝西亞病臨床試驗名稱：B-Free慢性巴貝西亞病研究

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SXTPW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SXTPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","market":"US","secType":"STK","nameCN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","latestPrice":0.1,"timestamp":1773757916726,"preClose":0.1,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":4104469,"shares":4104469,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"03-17 10:31:56 EDT","open":0.1,"high":0.1,"low":0.1,"amount":68.36469953000001,"amplitude":0,"askPrice":0.1,"askSize":5468,"bidPrice":0.045,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773777600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","floatShares":4104469,"roa":"-71.91%","roe":"-127.46%","lyrEps":0,"shares":4104469,"dividePrice":0,"high":0.1,"amplitude":0,"preClose":0.1,"low":0.1,"week52Low":0.02,"pbRate":"-0.12","psRate":"0.89","week52High":0.156,"institutionHeld":0,"latestPrice":0.1,"committee":-0.998173,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.1,"prevYearClose":0.0628,"prevWeekClose":0.0455,"prevMonthClose":0.0446,"prevQuarterClose":0.0628,"fiveDayClose":0.038,"twentyDayClose":0.0557,"sixtyDayClose":0.065},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTPW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1111655792","title":"60 Degrees Pharmaceuticals攜手Runway Health為國際旅行者提供瘧疾預防藥物Arakoda®直供服務","url":"https://stock-news.laohu8.com/highlight/detail?id=1111655792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111655792?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 21:02","pubTimestamp":1769086950,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals与Runway Health达成战略合作，将共同为国际旅行者开辟Arakoda疟疾预防药物的直接获取渠道。该合作旨在通过数字化健康平台，为出境人员提供便捷的疟疾预防解决方案。此次合作将整合60 Degrees Pharmaceuticals在热带病防治领域的专业优势与Runway Health的创新医疗服务平台，确保旅行者能够及时获得经临床验证的疟疾预防药物。Arakoda作为美国FDA批准的新型疟疾预防药物，其便捷的用药方案特别适合长期跨境旅行者需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","SXTPW","BK4007"],"gpt_icon":0},{"id":"1145415013","title":"60度製藥公司讚助研究顯示：北卡羅來納州立大學同行評審發現24%慢性疲勞患者存在巴貝西蟲感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1145415013","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145415013?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 21:02","pubTimestamp":1767013374,"startTime":"0","endTime":"0","summary":"一项由60度制药公司资助、在北卡罗来纳州立大学开展的同行评审研究揭示，在表现为慢性疲劳症状的患者群体中，巴贝西虫感染的检出率高达24%。该研究成果为慢性疲劳综合征与寄生虫感染之间的潜在关联提供了新的临床证据。\n研究数据表明，近四分之一长期受困于不明原因疲劳的患者，其症状可能与巴贝西虫属原虫感染存在病理学联系。这一发现不仅为慢性疲劳的病因诊断开辟了新视角，也可能推动相关靶向治疗方案的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"gpt_icon":0},{"id":"1104126707","title":"60 Degrees Pharmaceuticals 宣佈 B-Free 慢性巴貝斯病研究的臨床試驗中心已開放病人入組，地點位於西奈山伊坎醫學院","url":"https://stock-news.laohu8.com/highlight/detail?id=1104126707","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104126707?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 21:01","pubTimestamp":1763730076,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心现已开放病人入组，地点位于西奈山伊坎医学院。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTPW","SXTP"],"gpt_icon":0},{"id":"1144509557","title":"60 Degrees Pharmaceuticals宣佈在複發性巴貝斯蟲病研究中，首位患者接受塔非喹治療後未發現巴貝斯蟲感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1144509557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144509557?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 19:15","pubTimestamp":1760526909,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals宣布在复发性巴贝斯虫病研究中，首位患者接受塔非喹治疗后未发现巴贝斯虫感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"1194045758","title":"60 Degrees Pharmaceuticals公布慢性巴貝西亞病臨床試驗名稱：B-Free慢性巴貝西亞病研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1194045758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194045758?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 19:32","pubTimestamp":1760009565,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals公布慢性巴贝西亚病临床试验名称：B-Free慢性巴贝西亚病研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","BK4007","SXTP"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}